Abiomed
ABMD
#1261
Rank
$11.63 B
Marketcap
$255.32
Share price
2.69%
Change (1 day)
-18.12%
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Revenue for Abiomed (ABMD)

Revenue in 2022 (TTM): $1.03 B

According to Abiomed's latest financial reports the company's current revenue (TTM) is $1.03 B. In 2021 the company made a revenue of $1.00 B an increase over the years 2020 revenue that were of $0.81 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abiomed from 2001 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$1.03 B2.85%
2021$1.00 B23.4%
2020$0.81 B-3.37%
2019$0.84 B14.21%
2018$0.73 B35.42%
2017$0.54 B31.22%
2016$0.41 B36.76%
2015$0.30 B42.2%
2014$0.21 B20.52%
2013$0.17 B16.53%
2012$0.15 B29.12%
2011$0.11 B22.97%
2010$0.09 B16.14%
2009$0.08 B15.72%
2008$0.07 B28.67%
2007$0.05 B9.27%
2006$0.05 B24.47%
2005$0.04 B11.79%
2004$0.03 B50.87%
2003$0.02 B-11.03%
2002$0.02 B21.2%
2001$0.02 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$12.16 B 1,078.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.81 B 173.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.28 B-71.93%๐Ÿ‡บ๐Ÿ‡ธ USA